SEARCH
Quotes News NAV
Balance Sheet Markets  >  Corporate Information  >   Balance Sheet
Aptus Pharma Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544529 INE15XJ01010 29.1342566 Not Listed 0 105.47 0 0 10
      ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
SOURCES OF FUNDS :   
Share Capital 5.000.300.30
Reserves Total 1.971.470.67
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Total Shareholders Funds6.971.770.97
Secured Loans 6.991.580.33
Unsecured Loans 3.363.731.89
Total Debt10.355.312.22
Other Liabilities0.250.170.11
Total Liabilities17.577.253.30
APPLICATION OF FUNDS :   
Gross Block 1.861.240.91
Less : Accumulated Depreciation 0.870.600.39
Less:Impairment of Assets0.000.000.00
Net Block 0.990.640.52
Lease Adjustment0.000.000.00
Capital Work in Progress0.000.000.00
Producing Properties0.000.000.00
Investments 0.000.000.00
Current Assets, Loans & Advances   
Inventories 7.063.432.30
Sundry Debtors 5.643.352.40
Cash and Bank Balance5.210.910.54
Loans and Advances 1.830.620.41
Total Current Assets19.748.325.65
Less : Current Liabilities and Provisions   
Current Liabilities 3.182.422.79
Provisions 1.170.360.14
Total Current Liabilities & Provisions4.352.792.92
Net Current Assets15.395.532.72
Miscellaneous Expenses not written off 0.000.000.00
Deferred Tax Assets0.070.060.04
Deferred Tax Liability0.000.000.00
Net Deferred Tax0.070.060.04
Other Assets1.121.020.01
Total Assets17.577.243.29
Contingent Liabilities0.000.000.00